Assignee
RACTIGEN THERAPEUTICS
CN·0 granted patents·14 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
14 records- 0157US2025101421A1Oligonucleotide modulators activating utrophin expressionRACTIGEN THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0252US2025297258A1Oligonucleotide-based delivery vehicle for oligonucleotides agents and methods of use thereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0350US2024327833A1Double-Stranded Nucleic Acid Molecule for Treating Proliferative Vitreoretinopathy and Use ThereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0450US2024301409A1Chemically Modified Small Activating RNARACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0550US2024318174A1Multi-Valent Oligonucleotide Agent and Methods of Use ThereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0646US2022064642A1Oligomeric nucleic acid molecule and application thereofRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0745US2023212565A1Nucleic acid molecule for treating thrombocytopenia and application thereofRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0843US2023220389A1Nucleic acid molecule targeting mitf gene and use thereofRACTIGEN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0943US2023287416A1Combinatory treatment of sma with sarna and mrna modulatorsRACTIGEN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1041US2022313721A1Oligomeric nucleic acid molecule activating atoh1 gene and use thereofRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1139US2022096350A1Oligonucleotides for skin careRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1238US2022096516A1Oligonucleotide molecule and application thereof in tumor therapyRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1336US2021332366A1Novel Small Activating RNARACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1433US2021024915A1Method for activating p21 gene expressionRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →